Cargando…

Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune condition characterized, among others, by tissue damage and activation/differentiation of proinflammatory lymphocytes. Accordingly, several studies have concluded that type 17 T helper (Th17) cells seem to have an important role in the pathogenesis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitales-Noyola, Marlen, Hernández-Castro, Berenice, Alvarado-Hernández, Diana, Baranda, Lourdes, Bernal-Silva, Sofía, Abud-Mendoza, Carlos, Niño-Moreno, Perla, González-Amaro, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392632/
https://www.ncbi.nlm.nih.gov/pubmed/35996623
http://dx.doi.org/10.1155/2022/5398743
_version_ 1784771107041050624
author Vitales-Noyola, Marlen
Hernández-Castro, Berenice
Alvarado-Hernández, Diana
Baranda, Lourdes
Bernal-Silva, Sofía
Abud-Mendoza, Carlos
Niño-Moreno, Perla
González-Amaro, Roberto
author_facet Vitales-Noyola, Marlen
Hernández-Castro, Berenice
Alvarado-Hernández, Diana
Baranda, Lourdes
Bernal-Silva, Sofía
Abud-Mendoza, Carlos
Niño-Moreno, Perla
González-Amaro, Roberto
author_sort Vitales-Noyola, Marlen
collection PubMed
description Rheumatoid arthritis (RA) is a chronic autoimmune condition characterized, among others, by tissue damage and activation/differentiation of proinflammatory lymphocytes. Accordingly, several studies have concluded that type 17 T helper (Th17) cells seem to have an important role in the pathogenesis of this condition. However, the strategy for the identification and analysis of proinflammatory Th17 cells in those studies has not been consistent and has usually been different from what was originally described. Therefore, we decided to evaluate the levels of Th17 cells in patients with RA employing an extended immune phenotype by using an eight-color multiparametric flow cytometry analysis. For this purpose, blood samples were obtained from 30 patients with RA and 16 healthy subjects, and the levels of Th17 and type 22 helper (Th22) lymphocytes were analyzed as well as the in vitro differentiation of peripheral blood mononuclear cells into Th17 lymphocytes induced by interleukin-23 (IL-23) and IL-1β. We found significant enhanced levels of total Th17 lymphocytes (defined as CD4(+)IL-17(+)) as well as enhanced numbers of their pathogenic (defined as CD4(+)CXCR3(+)IL-17(+)IL-22(+)CD243(+)CD161(+)IFN-γ(+)IL-10(−)) and nonpathogenic (CD4(+)CXCR3(+)IL-17(+)IL-22(−)CD243(−)CD161(−)IFN-γ(−)IL-10(+)) cell subsets in patients with RA. Likewise, the number of Th22 (CD4(+)CXCR3(+/-)IL-17(−)IL-22(+)) was also increased in these patients compared to healthy controls. However, the in vitro induction/differentiation of pathogenic Th17 cells showed similar results in controls and patients with RA. Likewise, no significant associations were detected in patients with RA between the levels of Th17 or Th22 cells and clinical or laboratory parameters. Our data indicate that patients with RA show enhanced blood levels of the different subsets of Th17 cells and Th22 lymphocytes tested in this study and suggest that these levels are not apparently associated with clinical or laboratory parameters.
format Online
Article
Text
id pubmed-9392632
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93926322022-08-21 Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis Vitales-Noyola, Marlen Hernández-Castro, Berenice Alvarado-Hernández, Diana Baranda, Lourdes Bernal-Silva, Sofía Abud-Mendoza, Carlos Niño-Moreno, Perla González-Amaro, Roberto J Immunol Res Research Article Rheumatoid arthritis (RA) is a chronic autoimmune condition characterized, among others, by tissue damage and activation/differentiation of proinflammatory lymphocytes. Accordingly, several studies have concluded that type 17 T helper (Th17) cells seem to have an important role in the pathogenesis of this condition. However, the strategy for the identification and analysis of proinflammatory Th17 cells in those studies has not been consistent and has usually been different from what was originally described. Therefore, we decided to evaluate the levels of Th17 cells in patients with RA employing an extended immune phenotype by using an eight-color multiparametric flow cytometry analysis. For this purpose, blood samples were obtained from 30 patients with RA and 16 healthy subjects, and the levels of Th17 and type 22 helper (Th22) lymphocytes were analyzed as well as the in vitro differentiation of peripheral blood mononuclear cells into Th17 lymphocytes induced by interleukin-23 (IL-23) and IL-1β. We found significant enhanced levels of total Th17 lymphocytes (defined as CD4(+)IL-17(+)) as well as enhanced numbers of their pathogenic (defined as CD4(+)CXCR3(+)IL-17(+)IL-22(+)CD243(+)CD161(+)IFN-γ(+)IL-10(−)) and nonpathogenic (CD4(+)CXCR3(+)IL-17(+)IL-22(−)CD243(−)CD161(−)IFN-γ(−)IL-10(+)) cell subsets in patients with RA. Likewise, the number of Th22 (CD4(+)CXCR3(+/-)IL-17(−)IL-22(+)) was also increased in these patients compared to healthy controls. However, the in vitro induction/differentiation of pathogenic Th17 cells showed similar results in controls and patients with RA. Likewise, no significant associations were detected in patients with RA between the levels of Th17 or Th22 cells and clinical or laboratory parameters. Our data indicate that patients with RA show enhanced blood levels of the different subsets of Th17 cells and Th22 lymphocytes tested in this study and suggest that these levels are not apparently associated with clinical or laboratory parameters. Hindawi 2022-08-13 /pmc/articles/PMC9392632/ /pubmed/35996623 http://dx.doi.org/10.1155/2022/5398743 Text en Copyright © 2022 Marlen Vitales-Noyola et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Vitales-Noyola, Marlen
Hernández-Castro, Berenice
Alvarado-Hernández, Diana
Baranda, Lourdes
Bernal-Silva, Sofía
Abud-Mendoza, Carlos
Niño-Moreno, Perla
González-Amaro, Roberto
Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title_full Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title_fullStr Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title_full_unstemmed Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title_short Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
title_sort levels of pathogenic th17 and th22 cells in patients with rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392632/
https://www.ncbi.nlm.nih.gov/pubmed/35996623
http://dx.doi.org/10.1155/2022/5398743
work_keys_str_mv AT vitalesnoyolamarlen levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT hernandezcastroberenice levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT alvaradohernandezdiana levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT barandalourdes levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT bernalsilvasofia levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT abudmendozacarlos levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT ninomorenoperla levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis
AT gonzalezamaroroberto levelsofpathogenicth17andth22cellsinpatientswithrheumatoidarthritis